A QSAR Study of Matrix Metalloproteinases Type 2 (MMP-2) Inhibitors with Cinnamoyl Pyrrolidine Derivatives
Theoretical Medicinal and Environmental Chemistry Laboratory (LQMAT), Department of Pharmacy, Western Paraná State University (Unioeste), 2069 Universitária St, 8519110, CascaveI, PR, Brazil
Sci. Pharm. 2012, 80(2), 265-282; https://doi.org/10.3797/scipharm.1112-21
Submission received: 27 December 2011
/
Accepted: 31 January 2012
/
Published: 31 January 2012
Abstract
A multivariate PLS-QSAR study with a data set of 31 cinnamoyl pyrrolidine derivatives described as type 2 matrix metalloproteinases (MMP-2) inhibitors is presented in this paper. The variable selection was performed with the Ordered Predictors Selection (OPS) algorithm. The PLS model presented six descriptors and three Latent Variables (LV) that cumulated 71.845% of variance. Leave-N-out (LNO) cross validation and y-randomization tests showed that the model presented robustness and no chance correlation, respectively. The descriptors indicated that MMP-2 inhibition depends mainly on the electronic properties of the compounds. The model obtained can be useful as a support tool in the design of new MMP-2 inhibitors.
Keywords:
Matrix metalloproteinases; MMP2; Gelatinases; Cancer; QSAR; OPS
Share and Cite
MDPI and ACS Style
MELO, E.B.D. A QSAR Study of Matrix Metalloproteinases Type 2 (MMP-2) Inhibitors with Cinnamoyl Pyrrolidine Derivatives. Sci. Pharm. 2012, 80, 265-282. https://doi.org/10.3797/scipharm.1112-21
AMA Style
MELO EBD. A QSAR Study of Matrix Metalloproteinases Type 2 (MMP-2) Inhibitors with Cinnamoyl Pyrrolidine Derivatives. Scientia Pharmaceutica. 2012; 80(2):265-282. https://doi.org/10.3797/scipharm.1112-21
Chicago/Turabian StyleMELO, Eduardo Borges DE. 2012. "A QSAR Study of Matrix Metalloproteinases Type 2 (MMP-2) Inhibitors with Cinnamoyl Pyrrolidine Derivatives" Scientia Pharmaceutica 80, no. 2: 265-282. https://doi.org/10.3797/scipharm.1112-21
